Position in BMY
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$2,315,747
-$244,835 QoQ
Shares Held
40,190
-4.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#777
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CULLINAN ASSOCIATES INC holds $90,482,569 across 10 Drug Manufacturers - General names. BMY ranks #6 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
177,028 | $44,959,801 | |
| 2 | ABBV |
AbbVie Inc.
|
68,800 | $17,312,832 | |
| 3 | AMGN |
Amgen Inc
|
24,288 | $8,795,170 | |
| 4 | LLY |
ELI LILLY & Co
|
6,866 | $8,235,287 | |
| 5 | MRK |
Merck & Co., Inc.
|
46,620 | $5,990,670 | |
| 6 | BMY |
Bristol Myers Squibb Co
This page
|
40,190 | $2,315,747 | |
| 7 | PFE |
Pfizer Inc
|
51,301 | $1,235,328 | |
| 8 | NVS |
Novartis AG
|
4,700 | $736,584 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,315,747 | 40,190 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $2,560,582 | 42,219 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $2,750,616 | 50,994 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $2,508,416 | 55,619 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $3,051,945 | 65,931 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $4,264,420 | 69,920 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $4,049,922 | 71,604 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $4,772,083 | 92,232 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $4,383,740 | 105,556 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $5,929,399 | 109,338 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $5,863,912 | 114,284 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $8,147,016 | 140,369 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $8,593,792 | 134,383 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $11,354,502 | 163,822 | Shares | Sole | 2023-04-05 | |
| 2022-12-31 | $9,043,251 | 125,688 | Shares | Sole | 2023-01-11 | |
| 2022-09-30 | $7,889,426 | 110,978 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $7,643,405 | 99,265 | Shares | Sole | 2022-07-08 | |
| 2022-03-31 | $7,428,757 | 101,722 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $17,285,415 | 277,232 | Shares | Sole | 2022-01-07 | |
| 2021-09-30 | $16,273,643 | 275,032 | Shares | Sole | 2021-10-08 | |
| 2021-06-30 | $17,892,190 | 267,767 | Shares | Sole | 2021-07-07 | |
| 2021-03-31 | $15,923,469 | 252,233 | Shares | Sole | 2021-04-20 | |
| 2020-12-31 | $15,622,379 | 251,852 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $15,971,363 | 264,909 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $16,107,613 | 273,939 | Shares | Sole | 2020-07-07 | |
| 2020-03-31 | $15,233,407 | 273,294 | Shares | Sole | 2020-04-01 | |
| No filing history on record for this holder in this stock. | ||||||